Multiple endogenous receptors

The term "Multiple endogenous receptors" is a non-specific pharmacological designation used to describe a scenario where a drug or endogenous ligand interacts with a variety of different receptor proteins rather than a single, defined molecular target (Source: IUPHAR/BPS Guide to Pharmacology). This classification is frequently applied to pleiotropic signaling molecules or broad-spectrum therapeutic agents that exhibit polypharmacology, affecting multiple biological pathways simultaneously to produce a clinical effect (Source: Nature Reviews Drug Discovery). Because it does not identify a specific gene, protein, or molecular complex, it is not considered a valid canonical target in structured biochemical or genomic databases like UniProt or PubChem. In clinical contexts, this term may be used when the precise molecular mechanism involves a complex network of interactions that are not yet fully mapped or when the therapeutic benefit is derived from the sum of multiple receptor-mediated actions (Source: PubMed). Consequently, it lacks a specific molecular classification, biological function, or localized disease role, making it a placeholder for multi-target activity rather than a discrete entity. Targeting multiple receptors can be a deliberate strategy for treating complex diseases, but it also presents significant challenges in characterizing safety profiles and predicting off-target toxicities (Source: FDA).

Not applicable for a non-specific target category.